Navigation Links
Genmab Discloses Target and Development Plans for HuMax-Inflam
Date:9/13/2007

Summary: Genmab Reveals That HuMax-Inflam Target is IL-8 and Future

Development Will be in Cancer and Inflammation

COPENHAGEN, September 13 /PRNewswire-FirstCall/ -- Genmab A/S (OMX: GEN) announced today its fully human HuMax-Inflam(TM) antibody is directed to IL-8 (interleukin-8) and may have potential application in oncology and inflammation. Genmab will initially focus on studies to treat glioblastoma, a cancer of the central nervous system. Other possible indications include chronic obstructive pulmonary disease (COPD) and pustular dermatoses. In pre-clinical studies, HuMax-Inflam has been shown to inhibit tumor growth in tumor models using primary human tumors in immunodeficient mice. HuMax-Inflam was also effective in reducing disease activity in palmoplantar pustulosis patients in a clinical study.

Genmab is currently preparing an improved commercially viable cell line for HuMax-Inflam and hopes to start the next phase of clinical trials in 2008.

"Genmab's development plans for HuMax-Inflam have been a closely guarded secret for several years now and we are happy to announce the solution to the mystery, which has been much anticipated by the investment community," said Lisa N. Drakeman, Ph.D., Chief Executive Officer of Genmab. "We believe that HuMax-Inflam may have potential to treat patients with glioblastoma, which has a very low survival rate."

About HuMax-Inflam and IL-8

HuMax-Inflam is a high affinity fully human IgG1,k antibody directed towards IL-8. IL-8 is a major mediator of inflammation, a potent chemoattractant for white blood cells called neutrophils, as well as an important factor in angiogenesis. HuMax-Inflam effectively blocks binding of IL-8 to neutrophils and inhibits neutrophils from migrating towards sites of inflammation via a process known as chemotaxis. HuMax-Inflam also potently inhibits IL-8 induced neutrophil activation. In pre-clinical studies, HuMax-Inflam has been shown to inh
'/>"/>

SOURCE Genmab A/S
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Enhanced Amplification of Long Targets with PfuTurbo DNA Polymerase
2. Microarray Target Purification Kit and the Microarray Target Synthesis Kit (T7)
3. Gene Expression Arrays: Highly Sensitive Detection of Expression Patterns with Improved Tools for Target Amplification
4. Detection of antibody-stained cell surface and intracellular protein targets with the Agilent 2100 bioanalyzer
5. Protect RNA and Improve Target Cell Identification
6. Feasibility of Multiplexing Bio-Plex Total Target and Phosphoprotein Assays
7. Development of Radioligand Binding Assays for the Motilin Receptor Using ScreenReady Targets.
8. Calcium Plus Assay Kit, Superior Detection for Specialized Targets
9. ESR1 Gene Expression in Oncology and Metabolic Diseases Using the ASCENTATM System Target Validation and Identification of Novel Disease Indications
10. A Screen of shRNAs Targeting Tumor Suppressor Genes to Identify Factors Involved in Paclitaxel Sensitivity
11. TomoTherapy revises IPO money target

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/30/2009)..., Md., Nov. 30 Novavax, ...pany, announced today that the company will be pre...2009 on December 2, 2009 at 12:30 pm local time at...ide an overview of the company,s business strategy...ilestones. A link to the live audio only presenta...
(Date:11/30/2009)...v. 30 Dr. Jessica Torrente, Assist...iversity Medical Center in Washington, D.C., demon... Gamma Imaging (BSGI) in clinical practice as an a...t cancer today at the annual meeting of the Radiol... purpose of the exhibit was to demonstrate how BSG...
(Date:11/30/2009)...if., Nov. 30 BioMarin Ph... that the Food and Drug Administration (FDA) has g...dine (3,4-DAP), amifampridine phosphate, for the r...ndrome (LEMS). 3,4-DAP has previously received or...r 2009, the Committee for Medicinal Products for H...
(Date:11/30/2009)...nd COPENHAGEN, Nov. 30 Exiqon A/S ...t the Harvard Medical School ICCB-Longwood Screeni...oRNA Screening Center of Excellence. ICCB-L suppo...ssociated hospitals and institutions, for high-thr...ries. ,, MicroRNAs are a novel class of small, ...
Breaking Biology Technology:NOVAVAX to Present at the Piper Jaffray 21st Annual Health Care Conference 2Breast-Specific Gamma Imaging In Clinical Practice as an Adjunct Imaging Modality for Diagnosis of Breast Cancer 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 2Exiqon Recognizes Harvard Medical School Core Facility as MicroRNA Screening Center of Excellence 3
...- $15 million development milestone payment to Int...ram in Phase 2 -, BRISBANE, Calif., Sept. 2 Inte...InterMune has earned a $15 million,development mil...che for,the hepatitis C virus (HCV) NS3 protease i...t Roche), currently in a Phase 1b clinical trial i...
...SAN MATEO, Calif., Sept. 2 NeurogesX, Inc.,(Nasda... developing and,commercializing novel pain managem...o, President and Chief Executive Officer, is sched...hcare Unplugged Conference in New,York City on Tue...higlieri,Chief Financial Officer, will be availabl...
...BETHESDA, Md., Sept. 2 Micromet, Inc.,(Nasdaq: M...utical company,developing novel, proprietary antib... autoimmune diseases, today announced the appointm...t and Chief Financial Officer.,Mr. Phillips has se...rs,since 2000, and was the chair of the nominating...
Other Biology Technology:InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 2InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 3InterMune Earns Development Milestone in HCV Protease Inhibitor Collaboration With Roche 4NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference 2NeurogesX to Present at Morgan Stanley Global Healthcare Unplugged Conference 3Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer 2Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer 3Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer 4
(Date:11/26/2009)... at last worked out a way of using recordings of b...ulations. This is the first time sound recordings ...accurate estimates of bird species, populations. B...Ecological Society,s Journal of Applied Ecology ,...a major advance in our ability to monitor whale an...
(Date:11/25/2009)....Scientists at the California Institute of Technol...ve emotion-like behavior in the fruit fly, Drosop...be relevant to the relationship between the neurot...ivity disorder (ADHD), are described in the Decemb...ila brain contains only about 20,000 neurons and ...
(Date:11/25/2009)...VEMBER 25, 2009 Soil is the linchpin of the envir...re meet. Despite that, many students see soil as "...re. Soil science educators are challenged with the... the critical importance of soil in the environmen...d earth science teachers at University of Nebraska...
Breaking Biology News(10 mins):Ecologists sound out new solution for monitoring cryptic species 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4It's not just dirt! 2UN Gathering of Global Experts to Address Current Crisis in Family Planning 50103 1UN Gathering of Global Experts to Address Current Crisis in Family Planning 50103 2Too Few Americans Get HIV Test Early Enough 50100 1Too Few Americans Get HIV Test Early Enough 50100 2Too Few Americans Get HIV Test Early Enough 50100 3The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 1The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 2The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 3The Time To Rethink Male Circumcision Is Now Group Says In Launching www intactamerica org 50097 4
...shed the findings of a team of scientists at the n...t provides a whole genome analysis of the protein ...ism known as Dictyostelium. , Led by Dr. Janet S...e evolution of kinases, which are enzymes involved...5% of human genes code for protein kinases, and mu...
...earchers and their colleagues have discovered a ne...a cancer-causing virus found in mice. Their findin...fection with a retrovirus that is native to rodent...nts with a rare type of prostate cancer. The patie...romised some of their natural defenses against vir...
...nnesota were successful in using robotic surgery t...sue in pigs. , Using minimally invasive robotic s...lls into the damaged hearts. The cells were "label...be able to see if they engrafted in the pig hearts...six of seven cases. Subsequent MRI studies showed...
Other Biology News:Scientists elucidate the kinome of key model organism 2New human retrovirus originated in mice 2New human retrovirus originated in mice 3New human retrovirus originated in mice 4U of MN uses robotic surgery techniques in cardiac cell therapy research 2
BD FACSArray bioanalyzer from BD Biosciences - Immunocytometry Systems
...capability allows detection of SYBR Green I or FAM... in the second channel including TET, HEX, VIC, a...RT-qPCR and allelic discrimination. DNA Engine the... temperature gradient feature permits simultaneous...
SlideHyb Glass Array Hybridization Buffer #2 from Ambion
Fingerprinting II Informatix Dimensioning Techniques from Bio-Rad
Biology Products: